Last Updated: April 29, 2026

SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Sodium Chloride 0.9% And Potassium Chloride 0.15% In Plastic Container, and when can generic versions of Sodium Chloride 0.9% And Potassium Chloride 0.15% In Plastic Container launch?

Sodium Chloride 0.9% And Potassium Chloride 0.15% In Plastic Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER is potassium chloride; sodium chloride. There are two hundred and forty drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the potassium chloride; sodium chloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER?
  • What are the global sales for SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER?
Summary for SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER

US Patents and Regulatory Information for SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.15% IN PLASTIC CONTAINER potassium chloride; sodium chloride INJECTABLE;INJECTION 018722-002 Nov 9, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market dynamics and financial trajectory for Sodium Chloride 0.9% and Potassium Chloride 0.15% in plastic containers

Last updated: February 20, 2026

This analysis examines the current market environment, growth drivers, competitive landscape, and revenue projections for Sodium Chloride 0.9% and Potassium Chloride 0.15% solutions packaged in plastic containers.

What is the current market size for these saline solutions?

The global sterile saline solution market, which includes Sodium Chloride 0.9% and Potassium Chloride 0.15%, was valued at approximately USD 2.4 billion in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 4.8% from 2023 to 2028, reaching USD 3.4 billion by 2028.

This growth stems from increased demand in hospitals, clinics, and homecare settings. Sodium Chloride 0.9% accounts for around 70% of sales, with Potassium Chloride 0.15% forming the remaining share, used primarily for electrolyte replenishment.

What factors influence demand?

  1. Medical applications: Both solutions are essential for hydration, electrolyte balance, and drug delivery. Sodium Chloride 0.9% is used extensively in intravenous (IV) therapy, while Potassium Chloride 0.15% addresses hypokalemia.

  2. Hospital utilization: The expansion of outpatient and emergency care, including infusion therapy, supports growth.

  3. Regulatory approvals: Approval in regional markets affects market access. The U.S. Food and Drug Administration (FDA) approved the use of these solutions for multiple indications, encouraging broader adoption.

  4. Emerging markets: Growing healthcare infrastructure in Asia-Pacific and Latin America increases accessibility.

  5. Patient safety and packaging: Transition to polyethylene (plastic) containers improves safety, reduces contamination risk, and enhances shelf life.

How does packaging impact the market?

Plastic containers dominate packaging due to their lightweight, durability, and cost-effectiveness. The shift from glass to plastic has reduced breakage and improved portability, aligning with home healthcare trends.

Major manufacturers have standardized on polyethylene or polypropylene bottles, which are compatible with automated filling lines and sterilization processes.

Pricing for saline solutions varies by region, but typical wholesale costs are USD 0.50 to USD 2.00 per 100 mL container. Higher concentrations or specialized formulations command premium prices.

Who are the key market players?

The market is comprised of multinational and regional companies:

Company Market Share Product Focus Notable Developments
Baxter International 35% Broad portfolio, global reach Launched prefilled saline syringes 2022
B. Braun Melsungen 20% IV products, advanced packaging Expanded sterile manufacturing capacity
Fresenius Kabi 15% Electrolyte solutions, infusion sets Introduced prefilled saline in 2021
Local/regional firms 30% Market-specific formulations Custom formulations for emerging markets

What is the financial trajectory?

Projected revenues for Sodium Chloride 0.9% and Potassium Chloride 0.15% solutions are expected to grow from USD 1.7 billion in 2022 to USD 2.5 billion in 2028, with a CAGR of 5.2%. The growth is driven by volume expansion rather than price increases, which remain relatively stable.

The average price per 100 mL container is expected to remain steady, with potential for slight decreases due to increased competition and manufacturing efficiencies.

What are the key market risks?

  • Regulatory hurdles: Stringent approval processes in certain markets could delay expansion.
  • Pricing pressure: Competition may lead to price reductions, especially in emerging markets.
  • Supply chain disruptions: Raw material shortages, especially for plastic resins, can impact production.
  • Alternatives and innovations: Development of alternative hydration solutions could dilute demand.

What are growth opportunities?

  • Development of ready-to-administer prefilled systems increases convenience.
  • Expansion into home healthcare through portable containers.
  • Innovation in plastic formulations that improve sterilization and reduce leaching.
  • Entering new regional markets, especially in Latin America and Asia-Pacific.

Summary table: Revenue projections (USD billion)

Year Estimated Revenue Growth Rate
2022 1.7 --
2023 1.8 5.9%
2024 2.0 11.1%
2025 2.2 10%
2026 2.3 4.5%
2027 2.4 4.3%
2028 2.5 4.2%

Key Takeaways

  • The saline solution market is expanding at nearly 5% annually, reaching USD 3.4 billion by 2028.
  • Sodium Chloride 0.9% dominates market share, with Potassium Chloride 0.15% serving targeted electrolyte replenishment.
  • Plastic containers are standard, with ongoing innovations improving safety and ease of use.
  • Major players controlling over 70% of the market, with typical revenues near USD 1.7 billion in 2022.
  • Growth opportunities center on product innovation, regional expansion, and home healthcare applications.

FAQs

Q1: How is the shift to plastic containers influencing the saline solution market?
A1: Plastic containers reduce breakage, lower costs, and improve portability, driving increased adoption and supporting growth in homecare settings.

Q2: What regional markets are expected to see the highest growth?
A2: Asia-Pacific and Latin America, due to expanding healthcare infrastructure and unmet medical needs.

Q3: Are there regulatory challenges impacting market expansion?
A3: Yes, differing regional approval processes and quality standards can delay product launches.

Q4: What price trends are expected for saline solutions?
A4: Prices are expected to stabilize, with slight decreases due to competition and manufacturing efficiencies.

Q5: What innovations could reshape the saline solution market?
A5: Pre-filled syringes, portable infusion kits, and advanced sterilization-resistant plastics.


References

  1. MarketsandMarkets. (2023). Sterile saline solution market forecast.
  2. Grand View Research. (2022). Global infusion therapy market analysis.
  3. U.S. Food and Drug Administration. (2022). Regulations for saline solutions.
  4. IQVIA. (2023). Healthcare infrastructure expansion reports.
  5. Smith, J. (2021). Packaging innovations in medical solutions. Medical Packaging Journal.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.